| 149 | 32 | 13 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探究痰热清、氨溴索联合阿奇霉素治疗小儿支原体肺炎的机制,为支原体肺炎患儿的临床治疗提供帮助。方法:选取我院收治的86例支原体肺炎患儿,按随机数字表法分为观察组(43例)和对照组(43例),对照组给予基本治疗,观察组在此基础上给予痰热清、氨溴索和阿奇霉素的联合治疗,检测并探讨治疗前后两组支原体肺炎患儿肺功能指标潮气量(V-T)/kg、达峰时间比(t-PTEF/t-E)、呼出75%潮气量时的瞬间流速与潮气呼气峰流速比(TEF25/PTEF)以及吸气中期流速与呼气中期流速比(MTIF/MTEF),细胞因子白介素(IL)-2、IL-10、IL-6以及肿瘤坏死因子-α(TNF-α)及心肌酶谱指标乳酸脱氢酶(LDH)、肌酸激酶同工酶(CK-MB)、肌酸激酶(CK)、谷草转氨酶(AST)变化及机制。结果:治疗前两组支原体肺炎患儿肺功能、细胞因子及心肌酶谱比较差异无统计学差异(P>0.05)。与治疗前相比,两组支原体肺炎患儿经过相关治疗后MTIF/MTEF、心肌酶谱(LDH、CK-MB、CK及AST)和细胞因子(IL-10、IL-6以及TNF-α)显著降低,肺功能相关指标(V-T/kg、t-PTEF/t-E和TEF25/PTEF)和IL-2显著升高,差异存在统计学意义(P<0.05)。观察组经过联合治疗后患儿肺功能相关指标(VT/kg、t-PTEF/t-E和TEF25/PTEF)和IL-2显著高于治疗后对照组,MTIF/MTEF、心肌酶谱(LDH、CK-MB、CK及AST)和细胞因子(IL-10、IL-6以及TNF-α)显著低于治疗后对照组;组间差异存在统计学意义(P<0.05)。结论:痰热清、氨溴索和阿奇霉素联合治疗显著改善了支原体肺炎患儿的肺功能、细胞因子及心肌酶谱水平,对支原体肺炎患儿的治疗具有十分重要的临床意义。
Abstract：Objective:To observe the mechanism of Tanreqing and ambroxol combined with Azithromy for the treatment of mycoplasma pneumonia in children and offer help to mycoplasma pneumonia treatment.Methods:A total of 86 cases of mycoplasma pneumonia patients in our hospital were selected and randomly divided into observation group and control group,each group were 43 cases,control group was treated with conventional therapy,observation group was treated with Tanreqing and ambroxol combined with Azithromy based on conventional therapy,the changes of lung function(V-T/Kg,t-PTEF/t-E,TEF25/PTEF and MTIF/MTEF),cytokines(IL-2,IL-10,IL-6 and TNF-α)and the myocardial enzymes(LDH,CK-MB,CK and AST)were detected before and after treatment.Results:The comparison of lung function,cytokines and themyocardial enzymes in the two groups before treatment was not statistically significant(P>0.05).MTIF/MTEF,themyocardial enzymes(LDH,CK-MB,CK and AST)and cytokines(IL-10,IL-6 and TNF-α)in both groups after treatment significantly decreased compared with that before treatment;lung function(V-T/Kg,t-PTEF/t-E,TEF25/PTEF),and IL-2 in both groups after treatment significantly increased compared with that before treatment.The changes were statistically significant(P<0.05).lung function(V-T/Kg,t-PTEF/t-E,TEF25/PTEF),and IL-2 in observation group after treatment increased more significantly than that in control group,and MTIF/MTEF,themyocardial enzymes(LDH,CK-MB,CK and AST)and cytokines(IL-10,IL-6 and TNF-α)decreased more significantly than that in control group(P<0.05).Conclusion:Tanreqing and ambroxol combined with Azithromy could improve lung function,cytokines and the myocardial enzymes in children with mycoplasma pneumonia,which has a very important clinical significance of the treatment to mycoplasma pneumonia.
1 Paediatrics JGDO,Chang AB.Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children(Review)[J].Cochrane Database Syst Rev,2015,1(3):1-32.
2 Abuhammour W,Yilmaz C,Hurst M,et al.Central nervous system manifestations of Mycoplasma pneumoniae:Report of two children[J].J Pediatric Neurology Jpn,2015,3(3):183-187.
3 Canavan TN,Mathes EF,Frieden I,et al.Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme:A systematic review[J].J Am Acad Dermatol,2015,72(2):239-245.
4 钟秀梅,邓焰,楚雪梅.炎琥宁治疗对支原体肺炎患儿血清炎性因子和免疫功能的影响[J].海南医学院学报,2015,21(9):1262-1264.
5 Diaz MH,Benitez AJ,Winchell JM.Investigations of Mycoplasma pneumoniae infections in the United States:trends in molecular typing and macrolide resistance from 2006to 2013[J].J Clin Microbiol,2015,53(1):124-130.
6 Bai F,Ni B,Liu M,et al.Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce inflammation and apoptosis in porcine peripheral blood mononuclear cells in vitro[J].Vet Microbiol,2015,175(1):58-67.
7 Yuan ZF,Shen J,Mao SS,et al.Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection[J].BMC Infect Dis,2016,16(1):1-5.
8 Weiser GC,Drew ML,Cassirer EF,et al.Detection of Mycoplasma ovipneumoniae and M.arginini in bighorn sheep using enrichment culture coupled with genus-and species-specific polymerase chain reaction[J].J Wildlife Dis,2015,48(48):449-453.
9 杨华.氨溴特罗片联合阿奇霉素对支原体肺炎患儿抗炎、促炎因子及免疫功能的影响[J].海南医学院学报,2015,21(2):238-240.
10 Chalker VJ,Pereyre S,Dumke R,et al.International Mycoplasma pneumoniae typing study:interpretation of M.pneumoniae multilocus variable-number tandem-repeat analysis[J].New Microbes New Infect,2015,7(2):37-40.
11 Liu H,Ding H,Liu D,et al.Preparation,characterization of ambroxol hydrochloride resinates and investigation of the kinetics and thermodynamics of the ion exchange process[J].Lat Am J Pharm,2015,34(1):21-29.
12 冯涛.痰热清联合头孢曲松钠对慢性阻塞性肺疾病急性加重期的影响[J].实用老年医学,2015.29(8):656-658.
13 Sauteur PMM,Roodbol J,Hackenberg A,et al.Severe childhood Guillain-Barrésyndrome associated with Mycoplasma pneumoniae infection:a case series[J].J Peripher Nerv Syst,2015,20(2):72-78.
14 Jacobs E,Ehrhardt I,Dumke R.New insights in the outbreak pattern of Mycoplasma pneumoniae[J].Int J Med Microbiol,2015,305(7):705-708.
15 周建国,刘大男.他汀类药物对血脂异常患者血清炎症因子的影响[J].贵州医药,2015,39(9):844-845.
16 MitjàO,Houinei W,Moses P,et al.Mass treatment with single-dose azithromycin for yaws[J].New Engl J Med,2015,372(8):703-710.
17 Touati A,Blouin Y,Sirandpugnet P,et al.Molecular Epidemiology of Mycoplasma pneumoniae:genotyping using single nucleotide polymorphisms and SNaPshot technology[J].J Clin Microbiol,2015,53(10):3182-3194.
18 Zhou Z,Li X,Chen X,et al.Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang,China[J].Antimicrob Agents Ch,2015,59(2):1048-1051.
19 沈玉祥.布地奈德联合盐酸氨溴索雾化吸入对小儿支气管肺炎的疗效分析[J].河北医科大学学报,2012,33(6):712-714.
20 胡波.盐酸氨溴索联合布地奈德治疗小儿支气管肺炎的临床疗效及其对C反应蛋白和白细胞计数的影响[J].实用心脑肺血管病杂志,2015,(8):68-70.
基本信息:
DOI：10.13210/j.cnki.jhmu.20161114.011
中图分类号:R725.6
引用信息:
[1]余莉,何艳.痰热清、氨溴索联合阿奇霉素治疗小儿支原体肺炎的机制研究[J].海南医学院学报,2017,23(02):178-181.DOI:10.13210/j.cnki.jhmu.20161114.011.
基金信息:
重庆市卫生科技计划项目(201529214)~~
2016-11-14
2016-11-14
2016-11-14